Search Results 1-10 of 16149 for brca1%20and%20brca2%20genes%20and%20breast%20cancer

1. BRCA gene test for breast and ovarian cancer risk - Mayo Clinic

   Harmful changes in the genes can increase the risk of cancer. Healthcare professionals sometimes call these gene changes variants or mutations.

2. Beyond BRCA1/2: Pinpointing the risk of inherited breast cancer genes

   Immunohistochemistry for HER2 shows positive membrane staining in this infiltrating ductal carcinoma. At the molecular level, breast cancer is typically ...

3. BRCA gene test for breast and ovarian cancer risk - Care at Mayo Clinic

   Hereditary cancer risk can affect many parts of care. Mayo Clinic specialists work together to build a plan based on your genetic findings, cancer history, ...

4. Tissue-based breast cancer prevention in people with BRCA mutations - Tumor Microenvironment Laboratory - Mayo Clinic Research

   The Mayo Clinic Tumor Microenvironment Lab is studying BRCA breast cancer genes to find ways to intercept cancer before it begins.

5. BRCA Gene Test Clinical Trials - Mayo Clinic Research

   The purpose of this study is to improve the interpretation of mutations in breast cancer predisposition genes. This will be accomplished by recruiting members ...

6. BRCA gene test for breast and ovarian cancer risk - Doctors & Departments - Mayo Clinic

   Learn what to expect from BRCA gene testing, including how it helps study your risk of breast and ovarian cancer and what your results may mean.

7. Investigating Surgery for Women at High Risk of Breast and Ovarian Cancer - Mayo Clinic News Network

   BRCA1 carriers face an average cumulative risk of 67 percent for breast cancer and 45 percent for ovarian cancer by age 80. For BRCA2 carriers, those average ...

8. Mayo-led research team identifies genes that increase risk for triple-negative breast cancer

   However, he says it has been more difficult to identify women at elevated risk of triple-negative breast cancer because only inherited mutations in BRCA1 have ...

9. Researchers resolve uncertainty in BRCA2 testing, improving cancer risk assessment and patient care - Mayo Clinic News Network

   Many people with VUS may be notified about the reclassification of their VUS as the ClinVar BRCA1/2 expert panel and testing laboratories use the new ...

10. Triple-Negative Breast Cancer Patients Should Undergo Genetic Screening - Mayo Clinic News Network

    They found deleterious mutations in almost 15 percent of triple-negative breast cancer patients. Of these, 11 percent had mutations in the BRCA1 and BRCA2 genes ...